Actavis PLC $240.09

up +3.00


18/9/2014 11:30 AM  |  NYSE : ACT  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get ACT Trend Analysis - it has outperformed the S&P 500 by 55%

Partner Headlines

  1. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  2. Benzinga's Weekend M&A Chatter

    Benzinga
  3. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  4. Sterne Agee Still Has Confidence In Actavis plc

    Benzinga
  5. FDA Advisory Committee Recommends Against Approval of Actavis' Nebivolol/Valsartan ...

    Benzinga
  6. IBD 50 Showing Little Distress, But Few Big Winners

    IBD
  7. With Actively Managed Funds, Be Wary Of Expense Ratios

    Benzinga
  8. Sterne Agee Raises Actavis plc Estimates, Price Target

    Benzinga
  9. Shares Of Actavis Are Up ~1.5% On FDA Approval

    Benzinga
  10. UPDATE: Morgan Stanley Reiterates On Actavis plc As M&A Could Offer Additional ...

    Benzinga
  11. Actavis's Watson Labs ANDA Approved By FDA

    Benzinga
  12. Nasdaq Leads Mixed Session; Actavis Extends Gains

    IBD
  13. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga
  14. Bases Have Different Looks But Share Many Similarities

    IBD
  15. Dow Flirts With 19,000, S&P 500 Approaches 2,000 & Nasdaq Trading At 14-Year ...

    Benzinga
  16. Shares Of Depomed Moving Higher

    Benzinga
  17. Leaders Actavis, Salix Trip Sell Signals

    IBD
  18. Stocks Muted; Keurig Green Mountain Down After Hours

    IBD
  19. Drugmaker Q2 Profits Robust

    IBD
  20. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  21. Actavis Guidance Disappoints; Akorn Beats And Raises

    IBD
  22. UPDATE: Actavis Posts Upbeat Q2 Earnings, Raises Forecast

    Benzinga
  23. Earnings Scheduled For August 5, 2014

    Benzinga
  24. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  25. Many Leading Stocks Damaged As Market Tumbles Broadly

    IBD
  26. UPDATE: Bank Of America Reiterates On Actavis plc On Strong Strategic/Financial ...

    Benzinga
  27. Actavis May Give Buyers Another Chance

    IBD
  28. Diamond Hill Capital Comments on Actavis PLC

    GuruFocus
  29. Activis Shares Languish Post-Forest Deal

    Benzinga
  30. George Soros Reveals His Largest Stake

    GuruFocus
  31. Medicines360 And Actavis Announce FDA Acceptance For Filing Of NDA For ...

    Benzinga
  32. Enable Partners, Other Leaders Facing Market Pressure

    IBD
  33. Actavis Looks To Keep Up Momentum In Spite Of Yellen's Report

    Benzinga
  34. Facebook, Apple Suppliers Lead 5 Big-Cap All-Stars

    IBD
  35. Facebook, Apple Suppliers Lead 5 Big-Cap All-Stars

    IBD
  36. Actavis Fuels Growth With Acquisitions, New Generics

    IBD
  37. ACTAVIS

    IBD
  38. Stocks Ease Off Lows; King Digital Turns Tail

    IBD
  39. What Stocks Top Funds Are Buying Now

    IBD
  40. ACTAVIS

    IBD
  41. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  42. Many IBD 50 Stocks Struggle To Climb After Breakouts

    IBD
  43. Novo, Other Medicals Display Healthy Action

    IBD
  44. Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 5 ...

    Benzinga
  45. Diamond Hill Capital Comments on Actavis Inc

    GuruFocus
  46. Diamond Hill Small Cap Fund Commentary - First Quarter 2014

    GuruFocus
  47. Actavis and Forest Announce Tentative Election Deadline of June 27, 2014

    Benzinga
  48. Bulls Take A Break As Dow's Winning Streak Ends At 7 Days

    Benzinga
  49. Major Indexes Narrowly Lower As Actavis Rallies

    IBD
  50. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
Trading Center